The global PGLA Antibacterial Suture market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

PGLA antibacterial suture refers to surgical suture made of absorbable material PGLA (poly(lactic-co-glycolic acid), GA content >50%), generally made of polyglactin 910. And it has an antibacterial coating on the surface. The antibacterial agents used mainly include triclosan and chlorhexidine acetate.

From a downstream perspective, General Surgery accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

PGLA Antibacterial Suture leading manufacturers including Johnson & Johnson (Ethicon), Dolphin Sutures, Lotus Surgicals, The Healthium Group, Atramat, Meril Life Sciences, Boz Medical, Genesis Medtech, etc., dominate supply; the top five capture approximately % of global revenue, with Johnson & Johnson (Ethicon) leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global PGLA Antibacterial Suture market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of PGLA Antibacterial Suture Market Report

Report Metric	Details
Report Name	PGLA Antibacterial Suture Market
Segment by Type	Triclosan Coating Chlorhexidine Acetate Coating
Segment by Application	General Surgery Obstetrics and Gynecology Orthopedics Dental Medicine Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson (Ethicon), Dolphin Sutures, Lotus Surgicals, The Healthium Group, Atramat, Meril Life Sciences, Boz Medical, Genesis Medtech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the PGLA Antibacterial Suture study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the PGLA Antibacterial Suture Market report?

Ans: The main players in the PGLA Antibacterial Suture Market are Johnson & Johnson (Ethicon), Dolphin Sutures, Lotus Surgicals, The Healthium Group, Atramat, Meril Life Sciences, Boz Medical, Genesis Medtech

What are the Application segmentation covered in the PGLA Antibacterial Suture Market report?

Ans: The Applications covered in the PGLA Antibacterial Suture Market report are General Surgery, Obstetrics and Gynecology, Orthopedics, Dental Medicine, Others

What are the Type segmentation covered in the PGLA Antibacterial Suture Market report?

Ans: The Types covered in the PGLA Antibacterial Suture Market report are Triclosan Coating, Chlorhexidine Acetate Coating

1 Study Coverage

1.1 Introduction to PGLA Antibacterial Suture: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global PGLA Antibacterial Suture Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Triclosan Coating

1.2.3 Chlorhexidine Acetate Coating

1.3 Market Segmentation by Application

1.3.1 Global PGLA Antibacterial Suture Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 General Surgery

1.3.3 Obstetrics and Gynecology

1.3.4 Orthopedics

1.3.5 Dental Medicine

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global PGLA Antibacterial Suture Revenue Estimates and Forecasts 2020-2031

2.2 Global PGLA Antibacterial Suture Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global PGLA Antibacterial Suture Sales Estimates and Forecasts 2020-2031

2.4 Global PGLA Antibacterial Suture Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global PGLA Antibacterial Suture Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global PGLA Antibacterial Suture Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Triclosan Coating Market Size by Manufacturers

3.5.2 Chlorhexidine Acetate Coating Market Size by Manufacturers

3.6 Global PGLA Antibacterial Suture Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global PGLA Antibacterial Suture Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global PGLA Antibacterial Suture Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global PGLA Antibacterial Suture Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global PGLA Antibacterial Suture Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America PGLA Antibacterial Suture Sales and Revenue by Type (2020-2031)

6.4 North America PGLA Antibacterial Suture Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America PGLA Antibacterial Suture Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe PGLA Antibacterial Suture Sales and Revenue by Type (2020-2031)

7.4 Europe PGLA Antibacterial Suture Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe PGLA Antibacterial Suture Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific PGLA Antibacterial Suture Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific PGLA Antibacterial Suture Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific PGLA Antibacterial Suture Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America PGLA Antibacterial Suture Sales and Revenue by Type (2020-2031)

9.4 Central and South America PGLA Antibacterial Suture Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America PGLA Antibacterial Suture Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa PGLA Antibacterial Suture Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa PGLA Antibacterial Suture Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa PGLA Antibacterial Suture Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Johnson & Johnson (Ethicon)

11.1.1 Johnson & Johnson (Ethicon) Corporation Information

11.1.2 Johnson & Johnson (Ethicon) Business Overview

11.1.3 Johnson & Johnson (Ethicon) PGLA Antibacterial Suture Product Models, Descriptions and Specifications

11.1.4 Johnson & Johnson (Ethicon) PGLA Antibacterial Suture Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Johnson & Johnson (Ethicon) PGLA Antibacterial Suture Sales by Product in 2024

11.1.6 Johnson & Johnson (Ethicon) PGLA Antibacterial Suture Sales by Application in 2024

11.1.7 Johnson & Johnson (Ethicon) PGLA Antibacterial Suture Sales by Geographic Area in 2024

11.1.8 Johnson & Johnson (Ethicon) PGLA Antibacterial Suture SWOT Analysis

11.1.9 Johnson & Johnson (Ethicon) Recent Developments

11.2 Dolphin Sutures

11.2.1 Dolphin Sutures Corporation Information

11.2.2 Dolphin Sutures Business Overview

11.2.3 Dolphin Sutures PGLA Antibacterial Suture Product Models, Descriptions and Specifications

11.2.4 Dolphin Sutures PGLA Antibacterial Suture Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Dolphin Sutures PGLA Antibacterial Suture Sales by Product in 2024

11.2.6 Dolphin Sutures PGLA Antibacterial Suture Sales by Application in 2024

11.2.7 Dolphin Sutures PGLA Antibacterial Suture Sales by Geographic Area in 2024

11.2.8 Dolphin Sutures PGLA Antibacterial Suture SWOT Analysis

11.2.9 Dolphin Sutures Recent Developments

11.3 Lotus Surgicals

11.3.1 Lotus Surgicals Corporation Information

11.3.2 Lotus Surgicals Business Overview

11.3.3 Lotus Surgicals PGLA Antibacterial Suture Product Models, Descriptions and Specifications

11.3.4 Lotus Surgicals PGLA Antibacterial Suture Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Lotus Surgicals PGLA Antibacterial Suture Sales by Product in 2024

11.3.6 Lotus Surgicals PGLA Antibacterial Suture Sales by Application in 2024

11.3.7 Lotus Surgicals PGLA Antibacterial Suture Sales by Geographic Area in 2024

11.3.8 Lotus Surgicals PGLA Antibacterial Suture SWOT Analysis

11.3.9 Lotus Surgicals Recent Developments

11.4 The Healthium Group

11.4.1 The Healthium Group Corporation Information

11.4.2 The Healthium Group Business Overview

11.4.3 The Healthium Group PGLA Antibacterial Suture Product Models, Descriptions and Specifications

11.4.4 The Healthium Group PGLA Antibacterial Suture Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 The Healthium Group PGLA Antibacterial Suture Sales by Product in 2024

11.4.6 The Healthium Group PGLA Antibacterial Suture Sales by Application in 2024

11.4.7 The Healthium Group PGLA Antibacterial Suture Sales by Geographic Area in 2024

11.4.8 The Healthium Group PGLA Antibacterial Suture SWOT Analysis

11.4.9 The Healthium Group Recent Developments

11.5 Atramat

11.5.1 Atramat Corporation Information

11.5.2 Atramat Business Overview

11.5.3 Atramat PGLA Antibacterial Suture Product Models, Descriptions and Specifications

11.5.4 Atramat PGLA Antibacterial Suture Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Atramat PGLA Antibacterial Suture Sales by Product in 2024

11.5.6 Atramat PGLA Antibacterial Suture Sales by Application in 2024

11.5.7 Atramat PGLA Antibacterial Suture Sales by Geographic Area in 2024

11.5.8 Atramat PGLA Antibacterial Suture SWOT Analysis

11.5.9 Atramat Recent Developments

11.6 Meril Life Sciences

11.6.1 Meril Life Sciences Corporation Information

11.6.2 Meril Life Sciences Business Overview

11.6.3 Meril Life Sciences PGLA Antibacterial Suture Product Models, Descriptions and Specifications

11.6.4 Meril Life Sciences PGLA Antibacterial Suture Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Meril Life Sciences Recent Developments

11.7 Boz Medical

11.7.1 Boz Medical Corporation Information

11.7.2 Boz Medical Business Overview

11.7.3 Boz Medical PGLA Antibacterial Suture Product Models, Descriptions and Specifications

11.7.4 Boz Medical PGLA Antibacterial Suture Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Boz Medical Recent Developments

11.8 Genesis Medtech

11.8.1 Genesis Medtech Corporation Information

11.8.2 Genesis Medtech Business Overview

11.8.3 Genesis Medtech PGLA Antibacterial Suture Product Models, Descriptions and Specifications

11.8.4 Genesis Medtech PGLA Antibacterial Suture Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Genesis Medtech Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 PGLA Antibacterial Suture Industry Chain

12.2 PGLA Antibacterial Suture Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 PGLA Antibacterial Suture Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 PGLA Antibacterial Suture Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 PGLA Antibacterial Suture Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global PGLA Antibacterial Suture Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Johnson & Johnson (Ethicon)

List of Tables

Table 1. Global PGLA Antibacterial Suture Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global PGLA Antibacterial Suture Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global PGLA Antibacterial Suture Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global PGLA Antibacterial Suture Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global PGLA Antibacterial Suture Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global PGLA Antibacterial Suture Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global PGLA Antibacterial Suture Sales by Region (2020-2025) & (K Units)

Table 8. Global PGLA Antibacterial Suture Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global PGLA Antibacterial Suture Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global PGLA Antibacterial Suture Sales Share by Manufacturers (2020-2025)

Table 12. Global PGLA Antibacterial Suture Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global PGLA Antibacterial Suture Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global PGLA Antibacterial Suture by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PGLA Antibacterial Suture as of 2024)

Table 16. Global PGLA Antibacterial Suture Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global PGLA Antibacterial Suture Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers PGLA Antibacterial Suture Manufacturing Base and Headquarters

Table 19. Global PGLA Antibacterial Suture Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global PGLA Antibacterial Suture Sales by Type (2020-2025) & (K Units)

Table 23. Global PGLA Antibacterial Suture Sales by Type (2026-2031) & (K Units)

Table 24. Global PGLA Antibacterial Suture Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global PGLA Antibacterial Suture Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global PGLA Antibacterial Suture ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global PGLA Antibacterial Suture Sales by Application (2020-2025) & (K Units)

Table 29. Global PGLA Antibacterial Suture Sales by Application (2026-2031) & (K Units)

Table 30. PGLA Antibacterial Suture High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global PGLA Antibacterial Suture Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global PGLA Antibacterial Suture Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global PGLA Antibacterial Suture ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America PGLA Antibacterial Suture Growth Accelerators and Market Barriers

Table 37. North America PGLA Antibacterial Suture Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America PGLA Antibacterial Suture Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe PGLA Antibacterial Suture Growth Accelerators and Market Barriers

Table 40. Europe PGLA Antibacterial Suture Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe PGLA Antibacterial Suture Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific PGLA Antibacterial Suture Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific PGLA Antibacterial Suture Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific PGLA Antibacterial Suture Growth Accelerators and Market Barriers

Table 45. Southeast Asia PGLA Antibacterial Suture Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America PGLA Antibacterial Suture Investment Opportunities and Key Challenges

Table 47. Central and South America PGLA Antibacterial Suture Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa PGLA Antibacterial Suture Investment Opportunities and Key Challenges

Table 49. Middle East and Africa PGLA Antibacterial Suture Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Johnson & Johnson (Ethicon) Corporation Information

Table 51. Johnson & Johnson (Ethicon) Description and Major Businesses

Table 52. Johnson & Johnson (Ethicon) Product Models, Descriptions and Specifications

Table 53. Johnson & Johnson (Ethicon) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Johnson & Johnson (Ethicon) Sales Value Proportion by Product in 2024

Table 55. Johnson & Johnson (Ethicon) Sales Value Proportion by Application in 2024

Table 56. Johnson & Johnson (Ethicon) Sales Value Proportion by Geographic Area in 2024

Table 57. Johnson & Johnson (Ethicon) PGLA Antibacterial Suture SWOT Analysis

Table 58. Johnson & Johnson (Ethicon) Recent Developments

Table 59. Dolphin Sutures Corporation Information

Table 60. Dolphin Sutures Description and Major Businesses

Table 61. Dolphin Sutures Product Models, Descriptions and Specifications

Table 62. Dolphin Sutures Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Dolphin Sutures Sales Value Proportion by Product in 2024

Table 64. Dolphin Sutures Sales Value Proportion by Application in 2024

Table 65. Dolphin Sutures Sales Value Proportion by Geographic Area in 2024

Table 66. Dolphin Sutures PGLA Antibacterial Suture SWOT Analysis

Table 67. Dolphin Sutures Recent Developments

Table 68. Lotus Surgicals Corporation Information

Table 69. Lotus Surgicals Description and Major Businesses

Table 70. Lotus Surgicals Product Models, Descriptions and Specifications

Table 71. Lotus Surgicals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Lotus Surgicals Sales Value Proportion by Product in 2024

Table 73. Lotus Surgicals Sales Value Proportion by Application in 2024

Table 74. Lotus Surgicals Sales Value Proportion by Geographic Area in 2024

Table 75. Lotus Surgicals PGLA Antibacterial Suture SWOT Analysis

Table 76. Lotus Surgicals Recent Developments

Table 77. The Healthium Group Corporation Information

Table 78. The Healthium Group Description and Major Businesses

Table 79. The Healthium Group Product Models, Descriptions and Specifications

Table 80. The Healthium Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. The Healthium Group Sales Value Proportion by Product in 2024

Table 82. The Healthium Group Sales Value Proportion by Application in 2024

Table 83. The Healthium Group Sales Value Proportion by Geographic Area in 2024

Table 84. The Healthium Group PGLA Antibacterial Suture SWOT Analysis

Table 85. The Healthium Group Recent Developments

Table 86. Atramat Corporation Information

Table 87. Atramat Description and Major Businesses

Table 88. Atramat Product Models, Descriptions and Specifications

Table 89. Atramat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Atramat Sales Value Proportion by Product in 2024

Table 91. Atramat Sales Value Proportion by Application in 2024

Table 92. Atramat Sales Value Proportion by Geographic Area in 2024

Table 93. Atramat PGLA Antibacterial Suture SWOT Analysis

Table 94. Atramat Recent Developments

Table 95. Meril Life Sciences Corporation Information

Table 96. Meril Life Sciences Description and Major Businesses

Table 97. Meril Life Sciences Product Models, Descriptions and Specifications

Table 98. Meril Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Meril Life Sciences Recent Developments

Table 100. Boz Medical Corporation Information

Table 101. Boz Medical Description and Major Businesses

Table 102. Boz Medical Product Models, Descriptions and Specifications

Table 103. Boz Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Boz Medical Recent Developments

Table 105. Genesis Medtech Corporation Information

Table 106. Genesis Medtech Description and Major Businesses

Table 107. Genesis Medtech Product Models, Descriptions and Specifications

Table 108. Genesis Medtech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Genesis Medtech Recent Developments

Table 110. Key Raw Materials Distribution

Table 111. Raw Materials Key Suppliers

Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 113. Milestones in Production Technology Evolution

Table 114. Distributors List

Table 115. Market Trends and Market Evolution

Table 116. Market Drivers and Opportunities

Table 117. Market Challenges, Risks, and Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. PGLA Antibacterial Suture Product Picture

Figure 2. Global PGLA Antibacterial Suture Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Triclosan Coating Product Picture

Figure 4. Chlorhexidine Acetate Coating Product Picture

Figure 5. Global PGLA Antibacterial Suture Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. General Surgery

Figure 7. Obstetrics and Gynecology

Figure 8. Orthopedics

Figure 9. Dental Medicine

Figure 10. Others

Figure 11. PGLA Antibacterial Suture Report Years Considered

Figure 12. Global PGLA Antibacterial Suture Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 14. Global PGLA Antibacterial Suture Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global PGLA Antibacterial Suture Revenue Market Share by Region (2020-2031)

Figure 16. Global PGLA Antibacterial Suture Sales (2020-2031) & (K Units)

Figure 17. Global PGLA Antibacterial Suture Sales (CAGR) by Region (2020-2031) (K Units)

Figure 18. Global PGLA Antibacterial Suture Sales Market Share by Region (2020-2031)

Figure 19. Top 5 and Top 10 Manufacturers PGLA Antibacterial Suture Sales Volume Market Share in 2024

Figure 20. Global PGLA Antibacterial Suture Revenue Market Share Ranking (2024)

Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 22. Triclosan Coating Revenue Market Share by Manufacturer in 2024

Figure 23. Chlorhexidine Acetate Coating Revenue Market Share by Manufacturer in 2024

Figure 24. Global PGLA Antibacterial Suture Sales Market Share by Type (2020-2031)

Figure 25. Global PGLA Antibacterial Suture Revenue Market Share by Type (2020-2031)

Figure 26. Global PGLA Antibacterial Suture Sales Market Share by Application (2020-2031)

Figure 27. Global PGLA Antibacterial Suture Revenue Market Share by Application (2020-2031)

Figure 28. North America PGLA Antibacterial Suture Sales YoY (2020-2031) & (K Units)

Figure 29. North America PGLA Antibacterial Suture Revenue YoY (2020-2031) & (US$ Million)

Figure 30. North America Top 5 Manufacturers PGLA Antibacterial Suture Sales Revenue (US$ Million) in 2024

Figure 31. North America PGLA Antibacterial Suture Sales Volume (K Units) by Type (2020- 2031)

Figure 32. North America PGLA Antibacterial Suture Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 33. North America PGLA Antibacterial Suture Sales Volume (K Units) by Application (2020-2031)

Figure 34. North America PGLA Antibacterial Suture Sales Revenue (US$ Million) by Application (2020-2031)

Figure 35. US PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 36. Canada PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 37. Mexico PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 38. Europe PGLA Antibacterial Suture Sales YoY (2020-2031) & (K Units)

Figure 39. Europe PGLA Antibacterial Suture Revenue YoY (2020-2031) & (US$ Million)

Figure 40. Europe Top 5 Manufacturers PGLA Antibacterial Suture Sales Revenue (US$ Million) in 2024

Figure 41. Europe PGLA Antibacterial Suture Sales Volume (K Units) by Type (2020-2031)

Figure 42. Europe PGLA Antibacterial Suture Sales Revenue (US$ Million) by Type (2020-2031)

Figure 43. Europe PGLA Antibacterial Suture Sales Volume (K Units) by Application (2020-2031)

Figure 44. Europe PGLA Antibacterial Suture Sales Revenue (US$ Million) by Application (2020-2031)

Figure 45. Germany PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 46. France PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 47. U.K. PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 48. Italy PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 49. Russia PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific PGLA Antibacterial Suture Sales YoY (2020-2031) & (K Units)

Figure 51. Asia-Pacific PGLA Antibacterial Suture Revenue YoY (2020-2031) & (US$ Million)

Figure 52. Asia-Pacific Top 8 Manufacturers PGLA Antibacterial Suture Sales Revenue (US$ Million) in 2024

Figure 53. Asia-Pacific PGLA Antibacterial Suture Sales Volume (K Units) by Type (2020- 2031)

Figure 54. Asia-Pacific PGLA Antibacterial Suture Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 55. Asia-Pacific PGLA Antibacterial Suture Sales Volume (K Units) by Application (2020-2031)

Figure 56. Asia-Pacific PGLA Antibacterial Suture Sales Revenue (US$ Million) by Application (2020-2031)

Figure 57. Indonesia PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 58. Japan PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 59. South Korea PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 60. China Taiwan PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 61. India PGLA Antibacterial Suture Revenue (2020-2031) & (US$ Million)

Figure 62. Central and South America PGLA Antibacterial Suture Sales YoY (2020-2031) & (K Units)

Figure 63. Central and South America PGLA Antibacterial Suture Revenue YoY (2020-2031) & (US$ Million)

Figure 64. Central and South America Top 5 Manufacturers PGLA Antibacterial Suture Sales Revenue (US$ Million) in 2024

Figure 65. Central and South America PGLA Antibacterial Suture Sales Volume (K Units) by Type (2021-2031)

Figure 66. Central and South America PGLA Antibacterial Suture Sales Revenue (US$ Million) by Type (2020-2031)

Figure 67. Central and South America PGLA Antibacterial Suture Sales Volume (K Units) by Application (2020-2031)

Figure 68. Central and South America PGLA Antibacterial Suture Sales Revenue (US$ Million) by Application (2020-2031)

Figure 69. Brazil PGLA Antibacterial Suture Revenue (2020-2025) & (US$ Million)

Figure 70. Argentina PGLA Antibacterial Suture Revenue (2020-2025) & (US$ Million)

Figure 71. Middle East, and Africa PGLA Antibacterial Suture Sales YoY (2020-2031) & (K Units)

Figure 72. Middle East and Africa PGLA Antibacterial Suture Revenue YoY (2020-2031) & (US$ Million)

Figure 73. Middle East and Africa Top 5 Manufacturers PGLA Antibacterial Suture Sales Revenue (US$ Million) in 2024

Figure 74. Middle East and Africa PGLA Antibacterial Suture Sales Volume (K Units) by Type (2021-2031)

Figure 75. South America PGLA Antibacterial Suture Sales Revenue (US$ Million) by Type (2020-2031)

Figure 76. Middle East and Africa PGLA Antibacterial Suture Sales Volume (K Units) by Application (2020-2031)

Figure 77. Middle East and Africa PGLA Antibacterial Suture Sales Revenue (US$ Million) by Application (2020-2031)

Figure 78. GCC Countries PGLA Antibacterial Suture Revenue (2020-2025) & (US$ Million)

Figure 79. Turkey PGLA Antibacterial Suture Revenue (2020-2025) & (US$ Million)

Figure 80. Egypt PGLA Antibacterial Suture Revenue (2020-2025) & (US$ Million)

Figure 81. South Africa PGLA Antibacterial Suture Revenue (2020-2025) & (US$ Million)

Figure 82. PGLA Antibacterial Suture Industry Chain Mapping

Figure 83. Regional PGLA Antibacterial Suture Manufacturing Base Distribution (%)

Figure 84. Global PGLA Antibacterial Suture Production Market Share by Region (2020-2031)

Figure 85. PGLA Antibacterial Suture Production Process

Figure 86. Regional PGLA Antibacterial Suture Production Cost Structure

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-14O17929

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Ozone Medical Instrument Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28E19710

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Knotless Tissue-Closure Device Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-11A18018

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Medical Device SPD (Supply-Processing-Distribution) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13W20069

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global PGLA Antibacterial Suture Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-39Z17695

Global PGLA Antibacterial Suture Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

PGLA Antibacterial Suture Market

Report Includes:

Scope of PGLA Antibacterial Suture Market Report

Chapter Outline

FAQ for this report

Who are the main players in the PGLA Antibacterial Suture Market report?

What are the Application segmentation covered in the PGLA Antibacterial Suture Market report?

What are the Type segmentation covered in the PGLA Antibacterial Suture Market report?

FEATURED COMPANIES

RELATED REPORTS